Cargando…
Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
Several different signaling pathways and molecular mechanisms have been identified as responsible for controlling critical functions in human cancer cells, such as selective growth and proliferative advantage, altered stress response favoring overall survival, vascularization, invasion and metastasi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486121/ https://www.ncbi.nlm.nih.gov/pubmed/36122506 http://dx.doi.org/10.1016/j.tranon.2022.101510 |
_version_ | 1784792208829841408 |
---|---|
author | Fu, Dongliao Hu, Zhigang Xu, Xinyang Dai, Xiaoyan Liu, Ziyi |
author_facet | Fu, Dongliao Hu, Zhigang Xu, Xinyang Dai, Xiaoyan Liu, Ziyi |
author_sort | Fu, Dongliao |
collection | PubMed |
description | Several different signaling pathways and molecular mechanisms have been identified as responsible for controlling critical functions in human cancer cells, such as selective growth and proliferative advantage, altered stress response favoring overall survival, vascularization, invasion and metastasis, metabolic rewiring, an abetting microenvironment, and immune modulation. This concise summary will provide a selective review of recent studies of key signal transduction pathways, including mitogen-activated protein kinase (MAPK) pathway, Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling, and Wnt/β-catenin signaling pathway, which are altered in cancer cells, as the novel and promising therapeutic targets. |
format | Online Article Text |
id | pubmed-9486121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Neoplasia Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94861212022-09-30 Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities Fu, Dongliao Hu, Zhigang Xu, Xinyang Dai, Xiaoyan Liu, Ziyi Transl Oncol Commentary Several different signaling pathways and molecular mechanisms have been identified as responsible for controlling critical functions in human cancer cells, such as selective growth and proliferative advantage, altered stress response favoring overall survival, vascularization, invasion and metastasis, metabolic rewiring, an abetting microenvironment, and immune modulation. This concise summary will provide a selective review of recent studies of key signal transduction pathways, including mitogen-activated protein kinase (MAPK) pathway, Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling, and Wnt/β-catenin signaling pathway, which are altered in cancer cells, as the novel and promising therapeutic targets. Neoplasia Press 2022-09-16 /pmc/articles/PMC9486121/ /pubmed/36122506 http://dx.doi.org/10.1016/j.tranon.2022.101510 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Fu, Dongliao Hu, Zhigang Xu, Xinyang Dai, Xiaoyan Liu, Ziyi Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities |
title | Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities |
title_full | Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities |
title_fullStr | Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities |
title_full_unstemmed | Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities |
title_short | Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities |
title_sort | key signal transduction pathways and crosstalk in cancer: biological and therapeutic opportunities |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486121/ https://www.ncbi.nlm.nih.gov/pubmed/36122506 http://dx.doi.org/10.1016/j.tranon.2022.101510 |
work_keys_str_mv | AT fudongliao keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities AT huzhigang keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities AT xuxinyang keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities AT daixiaoyan keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities AT liuziyi keysignaltransductionpathwaysandcrosstalkincancerbiologicalandtherapeuticopportunities |